Effects of Testosterone and Xanthopterin on Kidney Tumors Induced by Lead in Rats
Author Information
Author(s): F. J. C. Roe, E. Boyland, C. E. Dukes, B. C. V. Mitchley
Primary Institution: Chester Beatty Research Institute, Institute of Cancer Research: Royal Cancer Hospital
Hypothesis
Does the administration of testosterone or xanthopterin influence renal carcinogenesis induced by lead in rats?
Conclusion
Testosterone and xanthopterin did not affect the induction of kidney tumors by lead in rats.
Supporting Evidence
- 34 rats developed kidney tumors after lead exposure.
- Testosterone and xanthopterin did not increase or decrease tumor incidence.
- Chronic nephritis was present in all rats, but its severity did not correlate with tumor development.
Takeaway
Researchers wanted to see if two substances, testosterone and xanthopterin, could change how lead causes kidney tumors in rats, but they found that neither had any effect.
Methodology
200 male albino rats were divided into groups and injected with varying doses of lead phosphate, testosterone, and xanthopterin, then monitored for tumor development.
Limitations
The study did not determine if chronic nephritis was necessary for tumor induction, and the effects of lead exposure were not fully explored.
Participant Demographics
200 male albino rats of the Chester Beatty strain.
Want to read the original?
Access the complete publication on the publisher's website